' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

STEINER MARKUS
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikationen

18 Publikationen

2019

Beiträge in Fachzeitschriften

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
Zaborsky, N; Gassner, FJ; Höpner, JP; Schubert, M; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Egle, A;
Leukemia. 2019; 33(4):957-968
Originalarbeiten (Zeitschrift)

2018

Beiträge in Fachzeitschriften

Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S; Lang, R; Steiner, M; Aglas, L; Ferreira, F; Wallner, M; Hawranek, T; Gadermaier, G;
Clin Transl Allergy. 2018; 8: 39
Originalarbeiten (Zeitschrift)
Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.
Wolf, M; Aglas, L; Twaroch, TE; Steiner, M; Huber, S; Hauser, M; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Wallner, M; Ferreira, F;
J Allergy Clin Immunol. 2018; 141(4): 1488-1491.e5.
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Exome sequencing of tumors from the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
Egle, A; Gassner, FJ; Hopner, JP; Hebenstreit, D; Stark, R; Asslaber, D; Steiner, M; Geisberger, R; Greil, R; Zaborsky, N
ONCOL RES TREAT. 2018; 41: 31-31.
Abstracts (Zeitschrift)

2017

Beiträge in Fachzeitschriften

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.
Catakovic, K; Gassner, FJ; Ratswohl, C; Zaborsky, N; Rebhandl, S; Schubert, M; Steiner, M; Gutjahr, JC; Pleyer, L; Egle, A; Hartmann, TN; Greil, R; Geisberger, R;
Oncoimmunology. 2017; 7(1):e1371399
Originalarbeiten (Zeitschrift)
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa.
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; Del Rio, M; Duarte, B; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther. 2017; 25(11):2573-2584
Originalarbeiten (Zeitschrift)
Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266: 87-99.
Originalarbeiten (Zeitschrift)
Amb a 1 isoforms: Unequal siblings with distinct immunological features.
Wolf, M; Twaroch, TE; Huber, S; Reithofer, M; Steiner, M; Aglas, L; Hauser, M; Aloisi, I; Asam, C; Hofer, H; Parigiani, MA; Ebner, C; Bohle, B; Briza, P; Neubauer, A; Stolz, F; Jahn-Schmid, B; Wallner, M; Ferreira, F;
Allergy. 2017; 72(12): 1874-1882.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Low expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial
Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Steiner, M; Fuentes, CM; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Greil, R
ANN ONCOL. 2017; 28:
Abstracts (Zeitschrift)
Ex vivo COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa
Hainzl, S; Peking, P; Kocher, T; Murauer, E; Larcher, F; Duarte, B; Steiner, M; Bauer, J; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(5): S92-S92.
Abstracts (Zeitschrift)
CRISPR/Cas9 mediated gene correction of COL7A1
Hainzl, S; Peking, P; Kocher, T; Murauer, EM; Larcher, F; del Rio, M; Duarte, BG; Steiner, M; Klausegger, A; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S224-S224.
Abstracts (Zeitschrift)

2016

Beiträge in Fachzeitschriften

Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
Himly, M; Nandy, A; Kahlert, H; Thilker, M; Steiner, M; Briza, P; Neubauer, A; Klysner, S; van Ree, R; Buchheit, KH; Vieths, S; Ferreira, F;
Allergy. 2016; 71(4): 495-504.
Originalarbeiten (Zeitschrift)
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.
Steiner, M; Harrer, A; Himly, M;
Front Pharmacol. 2016; 7: 171
Übersichtsarbeiten
Elevated Toll-Like Receptor-Induced CXCL8 Secretion in Human Blood Basophils from Allergic Donors Is Independent of Toll-Like Receptor Expression Levels.
Steiner, M; Hawranek, T; Schneider, M; Ferreira, F; Horejs-Hoeck, J; Harrer, A; Himly, M;
PLOS ONE. 2016; 11(2): e0149275
Originalarbeiten (Zeitschrift)
The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.
Steiner, M; Huber, S; Harrer, A; Himly, M;
Biomed Res Int. 2016; 2016: 8232830
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Tissue microRNAs predicting the pattern of breast cancer metastases
Gampenrieder, SP; Hackl, H; Rinnerthaler, G; Steiner, M; Hufnagl, C; Hauser-Kronberger, C; Mlineritsch, B; Greil, R
EUR J CANCER. 2016; 57: S111-S111.
Abstracts (Zeitschrift)
CRISPR/Cas9-mediated gene correction of COL7A1 in dystrophic epidermolysis bullosa
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Koller, U
HUM GENE THER. 2016; 27(11): A144-A144.
Abstracts (Zeitschrift)
CRISPR/Cas9-mediated gene repair in the COL7A1 gene
Hainzl, S; Kocher, T; Murauer, EM; Larcher, F; Steiner, M; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)